Tiziana Life Sciences plc (the “Company”) Result of Annual General Meeting

NEXT STORY
Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC
PREV STORY
Global Keloid Treatment Market (2021 to 2026) – by Product, Type, End-user and Geography
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Allarity Therapeutics and Lantern Pharma Enter into Agreement for Future Clinical Development of Irofulven

author_avatar
NASDAQ Market News

Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis (AD) to be Presented on March 2, 2019 at American Academy of Dermatology Annual Meeting

author_avatar
NASDAQ Market News

TESARO Enters Asset Purchase Agreement with TerSera® Therapeutics LLC for VARUBI® in the U.S. and Canada

TESARO to Receive $40 Million, plus Potential for Additional Milestone Payments and Royalties TESARO ...

author_avatar
NASDAQ Market News